---
schema_version: "secwatch.filing_event.v1"
accession: "0001568651-26-000036"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:41:13.216527+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Oscar Health Q1 net income $679M ($2.07 EPS) vs $275M ($0.92) YoY; revenue $4.65B

## Summary
- Revenue $4.65B, up 53% YoY from $3.05B; net income $679M ($2.07 EPS) vs $275M ($0.92 EPS) YoY.
- Medical loss ratio improved to 70.5% from 75.4% YoY; SG&A ratio 15.2% from 15.8%.
- Membership increased to ~3.17M from ~2.04M, up 55% YoY.
- Adjusted EBITDA $727M vs $329M YoY; Company reaffirms full-year 2026 guidance.

## SEC filing metadata
- accession: 0001568651-26-000036
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000036/0001568651-26-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000036/oscr-20260506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001568651-26-000036
- JSON: https://secwatch.observer/filing/0001568651-26-000036.json
- Plain text: https://secwatch.observer/filing/0001568651-26-000036.txt

## Source-grounded claims
- claim_id: e975cf3358e239b859acb9d52ab55c085266c220
  claim: Oscar Health, Inc. reported first quarter ended March 31, 2026 results: revenue $4,647,194, net income $678,996, EPS $2.07. Guidance reaffirmed.
  evidence_excerpt: results press release dated February 10, 2026. First Quarter 2026 Financial Highlights Three Months Ended March 31, (in thousands, except percentages) 2026 2025 Total revenue $4,647,194 $3,046,263 Medical loss ratio (“MLR”) 70.5% 75.4% Selling, general, and administrative (“SG&A”) expense ratio 15.2% 15.8% Earnings from operations $704,085 $297,123 Net income
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000036/0001568651-26-000036-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.